phosphoramidon






507 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
401 12363040 Induction of apoptosis and CD10/neutral endopeptidase expression by jaspamide in HL-60 line cells. Cell Mol Life Sci 2002 Aug 3
402 12392915 Cardioprotective effects of phosphoramidon on myocardial structure and function in murine Chagas' disease. Int J Parasitol 2002 Nov 1
403 12393059 [Met5]enkephalin-Arg-Gly-Leu-induced antinociception is greatly increased by peptidase inhibitors. Eur J Pharmacol 2002 Oct 18 1
404 12431739 Extracellular peptidases of imaginal discs of Drosophila melanogaster. Peptides 2002 Nov 2
405 12434178 Effect of endothelin-converting enzyme inhibitors on big endothelin-1 induced contraction in isolated rat basilar artery. Acta Neurochir (Wien) 2002 Nov 1
406 12477147 Vascular endothelin converting enzyme-1 expression and activity is upregulated in clinical diabetes. Ethn Dis 2002 Fall 2
407 12499645 Mechanical stretch-induced mitogen-activated protein kinase activation is mediated via angiotensin and endothelin systems in vascular smooth muscle cells. Biol Pharm Bull 2002 Dec 1
408 12541324 Identification and localization of a neprilysin-like activity that degrades tachykinin-related peptides in the brain of the cockroach, Leucophaea maderae, and locust, Locusta migratoria. J Comp Neurol 2003 Feb 24 1
409 12654643 Pseudomonas aeruginosa elastase degrades surfactant proteins A and D. Am J Respir Cell Mol Biol 2003 Apr 2
410 12827039 The effects of phosphoramidon on the expression of human endothelin-converting enzyme-1 (ECE-1) isoforms. J Cardiovasc Pharmacol 2003 Jul 5
411 12885426 Cerebral angiogenesis and expression of VEGF after subarachnoid hemorrhage (SAH) in rats. Brain Res 2003 Aug 15 1
412 12962299 [D-Val22]big ET-1[16-38] inhibits endothelin-converting enzyme activity: a promising concept in the prevention of cerebral vasospasm. Neurosurg Rev 2003 May 2
413 14500390 CD10 is a key enzyme involved in the activation of tumor-activated peptide prodrug CPI-0004Na and novel analogues: implications for the design of novel peptide prodrugs for the therapy of CD10+ tumors. Cancer Res 2003 Sep 1 1
414 14501953 Metalloendopeptidase inhibition regulates phosphorylation of p38-mitogen-activated protein kinase and nitric oxide synthase in heart after endotoxemia. Shock 2003 Oct 8
415 14659804 A low dose of angiotensin II increases inotropism through activation of reverse Na(+)/Ca(2+) exchange by endothelin release. Cardiovasc Res 2003 Dec 1 1
416 14972450 Signal pathway involved in increased expression of neutral endopeptidase 24.11 by gonadotropin releasing hormone in choriocarcinoma cells. Placenta 2004 Feb-Mar 3
417 15148521 Occurrence of substance P(1-7) in the metabolism of substance P and its antinociceptive activity at the mouse spinal cord level. Methods Find Exp Clin Pharmacol 2004 Apr 1
418 15151517 Endothelins and their inhibition in the human skin microcirculation: ET[1-31], a new vasoconstrictor peptide. Br J Clin Pharmacol 2004 Jun 1
419 15172962 Endothelin-induced constriction of the ductus venosus in fetal sheep: developmental aspects and possible interaction with vasodilatory prostaglandin. Br J Pharmacol 2004 Jun 1
420 15177934 Involvement of MAP-kinase, PI3-kinase and EGF-receptor in the stimulatory effect of Neurotensin on DNA synthesis in PC3 cells. Regul Pept 2004 Aug 15 4
421 15764737 Potentiation of des-Arg9-kallidin-induced vasoconstrictor responses by metallopeptidase inhibition in isolated human umbilical artery. J Pharmacol Exp Ther 2005 Jun 1
422 15804063 [Protective effects of phosphoramidon on the experimental myocardial injury in rats]. Hunan Yi Ke Da Xue Xue Bao 2003 Dec 1
423 15874973 Cocaine- and amphetamine-regulated transcript (CART) peptide: a vasoactive role in the cerebral circulation. J Cereb Blood Flow Metab 2005 Oct 1
424 15956117 Endothelin-1 (1-31) is an intermediate in the production of endothelin-1 after big endothelin-1 administration in vivo. Hypertension 2005 Jul 7
425 15963503 Inhibition of neutral endopeptidase (NEP) facilitates neurogenic inflammation. Exp Neurol 2005 Sep 2
426 15969636 Characterization of endothelin-converting enzyme activities in ARPE-19 cells, a human retinal pigmented epithelial cell line. J Ocul Pharmacol Ther 2005 Jun 3
427 15993898 Neutral endopeptidase determines the severity of pancreatitis-associated lung injury. J Surg Res 2005 Sep 5
428 16021085 Contribution of endogenous endothelin-1 to basal vascular tone during normal pregnancy and preeclampsia. Am J Obstet Gynecol 2005 Jul 1
429 16117692 Localization of endothelin-converting enzyme in bovine optic nerve and retina. J Ocul Pharmacol Ther 2005 Aug 1
430 16169283 NEP inhibitors enhance C-type natriuretic peptide-induced relaxation in porcine isolated coronary artery. Vascul Pharmacol 2005 Oct 1
431 16280098 Endothelin-1-dependent up-regulation of leptin production in gastric mucosal injury by indomethacin. Inflammopharmacology 2005 5
432 16391412 Role of endothelin-1-dependent up-regulation of leptin in oral mucosal repair. J Physiol Pharmacol 2005 Dec 3
433 16406141 Angiotensin converting enzyme has an inhibitory role in CGRP metabolism in human skin. Peptides 2006 Apr 3
434 16633356 Enzymatic pathways involved in the generation of endothelin-1(1-31) from exogenous big endothelin-1 in the rabbit aorta. Br J Pharmacol 2006 Jun 1
435 17028040 Effects of big endothelin-1 in comparison with endothelin-1 on the microvascular blood flow velocity and diameter of rat mesentery in vivo. Microvasc Res 2006 Nov 5
436 17112488 Neprilysin protects human neuronal progenitor cells against impaired development caused by amyloid-beta peptide. Brain Res 2006 Dec 8 2
437 17157960 Expression of NEP2, a soluble neprilysin-like endopeptidase, during embryogenesis in Drosophila melanogaster. Peptides 2007 Jan 2
438 17196890 Cardiovascular effects of centrally applied endothelin-1 1-31 and its relationship to endothelin-1 1-21 in rats. Auton Neurosci 2007 May 30 2
439 17466482 Effect of chronic ethanol consumption on endothelin-1 generation and conversion of exogenous big-endothelin-1 by the rat carotid artery. Alcohol 2007 Mar 4
440 17507367 Increased expression of profibrotic neutral endopeptidase and bradykinin type 1 receptors in stenotic aortic valves. Eur Heart J 2007 Aug 1
441 17643133 The peptidase inhibitor CGS-26303 increases endothelin converting enzyme-1 expression in endothelial cells through accumulation of big endothelin-1. Br J Pharmacol 2007 Oct 2
442 17878706 The enhancing effects of peptidase inhibitors on the antinociceptive action of [Met5]enkephalin-Arg6-Phe7 in rats. J Pharmacol Sci 2007 Sep 1
443 17904426 Big ET-1 processing into vasoactive peptides in arteries and veins. Vascul Pharmacol 2007 Nov-Dec 1
444 18055635 Metabolic inactivation of the circadian transmitter, pigment dispersing factor (PDF), by neprilysin-like peptidases in Drosophila. J Exp Biol 2007 Dec 1
445 18296865 Great increase in antinociceptive potency of [Leu5]enkephalin after peptidase inhibition. J Pharmacol Sci 2008 Feb 1
446 18307123 Phosphoramidon, an endothelin-converting enzyme inhibitor, attenuates lipopolysaccharide-induced acute lung injury. Exp Lung Res 2008 Mar 4
447 18322380 Activation of the amyloid cascade by intracerebroventricular injection of the protease inhibitor phosphoramidon. Neurodegener Dis 2008 1
448 18463098 Overexpression of neprilysin reduces alzheimer amyloid-beta42 (Abeta42)-induced neuron loss and intraneuronal Abeta42 deposits but causes a reduction in cAMP-responsive element-binding protein-mediated transcription, age-dependent axon pathology, and premature death in Drosophila. J Biol Chem 2008 Jul 4 1
449 18586023 Role of endogenous endothelin-1 in post-ischemic cardiac dysfunction and norepinephrine overflow in rat hearts. Eur J Pharmacol 2008 Sep 4 1
450 18607539 Inhibition of neutral endopeptidase potentiates neutrophil activation during Mg-deficiency in the rat. Inflamm Res 2008 Jul 1